Sunday, 20 September 2026European Markets

TRIGANO And BETER BED Have A High Dividend Yield And Return On Equity In The Consumer Cyclical Sector.

Loading stream...

(vianews) - trigano (tri.pa) is among this list of stock assets with the highest dividend rate and return on equity on the consumer cyclical sector.

financial asset price forward dividend yield return on equity
trigano (tri.pa) €126.60 2.79% 19.15%
beter bed (bbed.as) €5.76 2.59% 23.28%

several euronext companies pay out dividends to its shareholders. the dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.

1. trigano (tri.pa)

2.79% forward dividend yield and 19.15% return on equity

trigano s.a., together with its subsidiaries, engages in the design, manufacture, marketing, and sale of leisure vehicles for individuals and professionals in europe. it offers camping cars, caravans, motorhomes, trailers, and outdoor habitats. the company also provides mobiles homes, spare parts, and accessories, as well as leisure financing services. it offers its products through dealer networks and distributors, as well as through its online sales site, triganostore.com. trigano s.a. was founded in 1935 and is based in paris, france.

earnings per share

as for profitability, trigano has a trailing twelve months eps of €13.54.

pe ratio

trigano has a trailing twelve months price to earnings ratio of 9.35. meaning, the purchaser of the share is investing €9.35 for every euro of annual earnings.

return on equity

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 19.15%.

more news about trigano.

2. beter bed (bbed.as)

2.59% forward dividend yield and 23.28% return on equity

beter bed holding n.v. retails and wholesales bedroom furnishing products in the netherlands and belgium. the company offers beds, box springs, mattresses, bed bases, and bed textiles, as well as home delivery services. it operates retail stores under the beter bed and beddenreus brand names. the company also markets its products under the bright, beter bed basic, element, kårlsson, m-concept, m line, topcare, wave, and leazzzy brands, as well as through online platforms. beter bed holding n.v. was founded in 1981 and is headquartered in uden, the netherlands.

earnings per share

as for profitability, beter bed has a trailing twelve months eps of €0.27.

pe ratio

beter bed has a trailing twelve months price to earnings ratio of 21.33. meaning, the purchaser of the share is investing €21.33 for every euro of annual earnings.

return on equity

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 23.28%.

dividend yield

according to morningstar, inc., the next dividend payment is on may 12, 2023, the estimated forward annual dividend rate is 0.15 and the estimated forward annual dividend yield is 2.59%.

volume

today's last reported volume for beter bed is 12160 which is 81.62% below its average volume of 66170.

moving average

beter bed's value is below its 50-day moving average of €5.76 and way above its 200-day moving average of €3.78.

more news about beter bed.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Boom Hits a Fork: Slowdown Calls Clash with Capex Confidence as Markets Get Nervous
Dario Amodei's repeated calls for a global slowdown in frontier AI development, echoed by Microsoft's new humanist AI code of conduct and FTC antitrust caution, are being publicly rejected by Nvidia and Meta leadership even as hyperscaler spending draws fresh skeptical scrutiny (Wachter's analysis, Burry-style overbuilding worries) and weak guidance from Adobe and a post-slowdown-comment selloff in GE Vernova signal investor jitters. Meanwhile wealth and security effects of the AI race keep compounding — Zhang Yiming's fortune surging on AI-driven ByteDance value, a Chinese hacking firm weaponizing AI against stolen government secrets, and low-quality AI-generated products (an AI sitcom, a spam-flooding agent platform) fueling backlash even as adoption races ahead.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Berkshire Hathaway
Both facts report Berkshire Hathaway's cash position on 2026-01-01 with identical observation timestamps, but claim vastly different values: 380 billion USD vs 400 USD. These cannot both be true for the same entity at the same point in time. The magnitude of the discrepancy (a factor of ~10^9) rules out rounding, unit conversion, or methodological differences.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,982
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,982 facts checked against source5,299 source documents archived
Query this data → isubstrate.com